Breast Metastatic Marker Test sale cost 880 AED
Immunophenotyping by Flow Cytometry CD16 and 56 Test sale cost 910 AED Immunophenotyping by Flow Cytometry CD16 and 56 Test Cost 1,010 د.إ Original price was: 1,010 د.إ.910 د.إCurrent price is: 910 د.إ.
Chromosome Analysis for Hematologic Malignancy Test sale cost 820 AED Chromosome Analysis for Hematologic Malignancy Test Cost 910 د.إ Original price was: 910 د.إ.820 د.إCurrent price is: 820 د.إ.
Sale!

Breast Metastatic Marker Test Cost

Original price was: 980 د.إ.Current price is: 880 د.إ.

-10%

The Breast Metastatic Marker Test is a crucial diagnostic tool available at DNA Labs UAE, designed to detect the presence of specific markers in the blood that are associated with the metastasis of breast cancer. This test plays a significant role in the management and treatment planning for patients with breast cancer by helping to determine whether the cancer has spread to other parts of the body. At a cost of 880 AED, the test offers a valuable resource for oncologists and patients alike in the fight against breast cancer, providing essential information that can guide therapy decisions, monitor treatment effectiveness, and potentially improve patient outcomes. DNA Labs UAE, known for its state-of-the-art facilities and expert medical staff, ensures accurate and reliable results for those undergoing the Breast Metastatic Marker Test.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

BREAST METASTATIC MARKER Test

At DNA Labs UAE, we offer the Breast Metastatic Marker Test to determine whether breast cancer has spread to other parts of the body. This test helps in staging the cancer and guiding treatment decisions.

Test Details

The Breast Metastatic Marker Test is a medical test used to determine whether breast cancer has spread to other parts of the body, particularly the lymph nodes or distant organs. This test helps in staging the cancer and guiding treatment decisions.

During the test, a sample of tissue or fluid from the affected area is taken and analyzed for specific markers that indicate the presence of metastasis. These markers may include proteins or genetic abnormalities associated with breast cancer.

Test Components

  • ER
  • PR
  • CA 15.3
  • Includes pathologist review for presence of malignant cells

Test Type

Cancer

Doctor

Oncologist

Test Department

Pre Test Information: Provide a copy of the Histopathology report, Clinical history & indicate site of biopsy.

Sample Condition

Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Clinical history & indicate site of biopsy.

Price

880.0 AED

Report Delivery

Sample: Daily by 6 pm

Report Block: 5 days

Tissue biopsy: 5 days

Tissue large complex: 7 days

Same Day: CA 15.3

Method

Immunohistochemistry, Chemiluminescent Immunoassay

Symptoms and Diagnosis

The Breast Metastatic Marker Test is typically performed after a breast cancer diagnosis has already been made to assess the extent of the disease. It is not a screening test for breast cancer. Symptoms of breast cancer may include a lump in the breast, changes in breast shape or size, nipple discharge, or skin changes.

Treatment Options

If metastasis is detected through the Breast Metastatic Marker Test, more aggressive treatments such as chemotherapy or targeted therapy may be recommended. The results of the test can help doctors determine the appropriate treatment options for the patient.

For more information or to schedule a test, please contact DNA Labs UAE.

Test Name BREAST METASTATIC MARKER Test
Components *ER*PR*CA 15.3*Includes pathologist review for presence of malignant cells
Price 880.0 AED
Sample Condition Submit tumor tissue in 10% Formal-saline \nOR Formalin fixedparaffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Clinical history & indicate site of biopsy.
Report Delivery Sample Daily by 6 pm; Report Block : 5 days Tissue biopsy : 5 days Tissue large complex : 7 days Same Day : CA 15.3
Method Immunohistochemistry, Chemiluminescent Immunoassay
Test type Cancer
Doctor Oncologist
Test Department:
Pre Test Information Provide a copy of the Histopathology report, Clinical history & indicate site of biopsy.
Test Details

The Breast Metastatic Marker Test is a medical test used to determine whether breast cancer has spread to other parts of the body, particularly the lymph nodes or distant organs. This test helps in staging the cancer and guiding treatment decisions.

During the test, a sample of tissue or fluid from the affected area is taken and analyzed for specific markers that indicate the presence of metastasis. These markers may include proteins or genetic abnormalities associated with breast cancer.

The results of the test can help doctors determine the appropriate treatment options for the patient. If metastasis is detected, more aggressive treatments such as chemotherapy or targeted therapy may be recommended.

It is important to note that the Breast Metastatic Marker Test is not a screening test for breast cancer. It is typically performed after a breast cancer diagnosis has already been made to assess the extent of the disease.

SKU: TEST-5946 Category:

Related products